Quest Diagnostics Incorporated

NYSE:DGX

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🏥 Hospitals & Clinics

🤝 Professional Services

🔍 Research & Consulting

💻 Telehealth

Location

United States

Market Cap

USD 18.87 B

Share Price

USD 168.73

Avg Daily Volume

1,126,867

Change (1 day)

0.48%

Change (1 year)

18.08%

Change (YTD)

11.85%

Quest Diagnostics Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2025: USD 1.68 B

Quest Diagnostics Incorporated Operating Cash Flow is USD 1.68 B for the Trailing 12 Months (TTM) ending June 30, 2025, a 34.46% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Quest Diagnostics Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 1.25 B, a -9.17% change year over year.
Quest Diagnostics Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2023 was USD 1.37 B, a -28.59% change year over year.
Quest Diagnostics Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2022 was USD 1.92 B, a -25.83% change year over year.
Quest Diagnostics Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2021 was USD 2.59 B, a 107.69% change year over year.